Gene directed enzyme prodrug therapy for cancer
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 26 (2-3) , 173-184
- https://doi.org/10.1016/s0169-409x(97)00033-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- A Phase I Study of Vaccination with Autologous, Irradiated Melanoma Cells Engineered to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor. Dana-Farber Cancer Institute, Boston, MassachusettsHuman Gene Therapy, 1997
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.Proceedings of the National Academy of Sciences, 1996
- Cancer vaccines: the interleukin 2 dosage effect.Proceedings of the National Academy of Sciences, 1995
- Genetics of colorectal cancerBritish Medical Bulletin, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proceedings of the National Academy of Sciences, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Molecular characterization and functional expression of the human cardiac gap junction channel.The Journal of cell biology, 1990